Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Fact checked by Jennifer Klump Adults aged 50 and older who have certain medical conditions are now eligible to get ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...

Vaccines are the best way to protect yourself from those illnesses, as well as from viruses such as RSV, influenza, and COVID-19. Experts say it’s increasingly important to safeguard yourself from all ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally.A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

As cases of respiratory syncytial virus (RSV) continue to rise, vaccines become harder to get due to new restrictions from health officials. The Children’s Hospital of Philadelphia sent a notice ...

A vaccination programme against a respiratory virus will be extended to cover premature babies born in Northern Ireland later ...

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans and examine the risk factors for intensive care unit (ICU) admission and ...

Pfizer reports its RSV vaccine reduced the risk of severe illness in older adults by 86%. In November 2022, the company announced findings from a trial that instead administered the shot to ...

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory ...

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...